Edition:
United States

Atara Biotherapeutics Inc (ATRA.OQ)

ATRA.OQ on NASDAQ Stock Exchange Global Select Market

42.25USD
22 Jun 2018
Change (% chg)

$-3.80 (-8.25%)
Prev Close
$46.05
Open
$46.05
Day's High
$46.10
Day's Low
$41.15
Volume
1,268,446
Avg. Vol
248,194
52-wk High
$54.45
52-wk Low
$12.75

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -1.047
FY 2017 Dec '17 0.00 -1.152
Sep '17 0.00 -1.020
Jun '17 0.00 -0.938
Mar '17 0.00 -0.883
FY 2016 Dec '16 0.00 -0.631
Sep '16 0.00 -0.881
Jun '16 0.00 -0.659
Mar '16 0.00 -0.580
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 6 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 6 0.00 0.00 0.00 0.00
Year Ending Dec-18 6 0.00 0.00 0.00 6.00
Year Ending Dec-19 6 0.83 2.98 0.00 80.73
Earnings (per share)
Quarter Ending Jun-18 7 -0.98 -0.84 -1.09 -0.96
Quarter Ending Sep-18 7 -1.00 -0.84 -1.10 -0.91
Year Ending Dec-18 7 -4.01 -3.58 -4.31 -3.82
Year Ending Dec-19 7 -4.23 -3.94 -4.69 -2.47
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 244.60 33.54
P/E High - Last 5 Yrs. -- 290.57 47.76
P/E Low - Last 5 Yrs. -- 100.09 25.07
Beta 2.57 0.74 0.79
Price to Sales (TTM) -- 253.05 8.28
Price to Book (MRQ) 4.60 23.78 4.21
Price to Tangible Book (MRQ) 4.69 30.85 6.00
Price to Cash Flow (TTM) -- 144.30 22.70
% Owned Institutions -- 12.00 2.44

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.74
Dividend Yield - 5 Year Avg -- 0.20 1.43
Dividend 5 Year Growth Rate -- 2.17 -6.29
Payout Ratio(TTM) -- 41.14 41.21

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 26.93 5.43
Sales (TTM) vs TTM 1 Yr. Ago -- 139.59 12.81
Sales - 5 Yr. Growth Rate -- 31.30 7.89
EPS (MRQ) vs Qtr. 1 Yr. Ago -18.54 -77.66 40.97
EPS (TTM) vs TTM 1 Yr. Ago -36.14 -- --
EPS - 5 Yr. Growth Rate -- 48.96 8.04
Capital Spending - 5 Yr. Growth Rate -- 36.68 7.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.55
Current Ratio (MRQ) 19.65 6.40 3.62
LT Debt to Equity (MRQ) 0.00 22.45 13.20
Total Debt to Equity (MRQ) 0.00 26.80 17.68
Interest Coverage (TTM) -- -139.93 36.44

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.67 55.10
Gross Margin - 5 Yr. Avg. -- 55.13 52.98
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -167.31 15.70
Operating Margin (TTM) -- -893.25 -0.37
Operating Margin - 5 Yr. Avg. -- -180.81 10.89
Pre-Tax Margin (TTM) -- -786.04 1.60
Pre-Tax Margin - 5 Yr. Avg. -- -184.17 11.06
Net Profit Margin (TTM) -- -779.78 -1.69
Net Profit Margin - 5 Yr. Avg. -- -182.64 7.42
Effective Tax Rate (TTM) -- 15.40 29.75
Effective Tax Rate - 5 Yr. Avg. -- 19.25 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 21,874,759 727,953,282
Net Income/Employee (TTM) -731,243 -152,114 84,747,764
Receivable Turnover (TTM) -- 18.30 6.05
Inventory Turnover (TTM) -- 2.83 3.67
Asset Turnover (TTM) 0.00 0.48 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -37.85 -3.57 10.32
Return on Assets - 5 Yr. Avg. -34.10 -0.71 10.99
Return on Investment (TTM) -39.44 -5.33 13.09
Return on Investment - 5 Yr. Avg. -35.69 2.10 14.27
Return on Equity (TTM) -40.24 -6.88 15.10
Return on Equity - 5 Yr. Avg. -39.11 -3.17 15.63
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -45.44 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Atara Biotherapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -9.79 -10.52 69 72
13 Week 19.77 15.15 99 36
26 Week 198.06 190.99 99 86
52 Week 220.91 184.24 99 86
YTD 154.42 147.37 99 85
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 171
Total Shares Held: 46,527,734
3 Mo. Net Change: 13,863,409
# New Positions: 52
# Closed Positions: 12
# Increased Positions: 123
# Reduced Positions: 31
# Net Buyers: 92
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.